IBANDRONIC ACID Oral monthly
Clinical Indication
Postmenopausal osteoporosis
Comments
In line with NICE TA 464
Use only when compliance with oral therapy is an issue
Date of classification
December 2017
Green
Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.